Efficacy of a novel iodine complex solution, CupriDyne, in inactivating SARS-CoV-2
| Autor: | Laura Patterson-Fortin, Alexander C.O. Evans, Jenny Boutros, Emily K. Mantlo, Richard S. Smith, Slobodan Paessler |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | bioRxiv article-version (status) pre article-version (number) 1 |
| Popis: | The coronavirus known as SARS-CoV-2, which causes COVID-19 disease, is presently responsible for a global pandemic wherein more than 3.5 million people have been infected and more than 250,000 killed to-date. There is currently no vaccine for COVID-19, leaving governments and public health agencies with little defense against the virus aside from advising or enforcing best practices for virus transmission prevention, which include hand-washing, physical distancing, use of face covers, and use of effective disinfectants. In this study, a novel iodine complex called CupriDyne® was assessed for its ability to inactivate SARS-CoV-2. CupriDyne was shown to be effective in inactivating the virus in a time-dependent manner, reducing virus titers by 99% (2 logs) after 30 minutes, and reducing virus titers to below the detection limit after 60 minutes. The novel iodine complex tested herein offers a safe and gentle alternative to conventional disinfectants for use on indoor and outdoor surfaces. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|